Is Pfizer Stock Still a Top Buy for 2021?
Pfizer (NYSE: PFE) has been in the news a lot lately, and for good reason. Its partnership with BioNTech to produce a COVID-19 vaccine was massively successful, resulting in huge demand. This was highlighted by a recent order of 1.8 billion vaccine doses from the European Union. Just in the past three months, Pfizer stock is up nearly 16%, while the SPDR S&P 500 ETF is up only 5.88%.
There are still a lot of things to be excited about with Pfizer, including future growth in its vaccine segment and its overall business. With all this positive news, here's why you might want to buy Pfizer stock in 2021.
Image source: Getty Images.
Source Fool.com
